Pharmacologic Therapy for Non ST-segment Elevation Acute Coronary Syndromes: Focus on Antithrombotic Therapy

By Danchin Nicolas   Aïssaoui Nadia  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 325-330

Springer Publishing Company

Access to resources Recommend Favorite

Antithrombotic Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes: Recommendations of the Rio de la Plata Expert Panel

By  

Clinical Drug Investigation, Vol. 19, Iss. 6, 2000-06 ,pp. : 409-420

Adis International

Access to resources Recommend Favorite

Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes

By Galla John M   Mahaffey Kenneth W  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite

Acute Coronary Syndromes Presenting with Transient Diffuse ST Segment Depression and ST Segment Elevation in Lead aVR not Caused by “Acute Left Main Coronary Artery Occlusion”: Description of Two Cases

By Kim Edward   Birnbaum Yochai  

Annals of Noninvasive Electrocardiology, Vol. 18, Iss. 2, 2013-03 ,pp. : 204-209

Blackwell Publishing

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications

By Hillegass W.B.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 41-55

Adis International

Access to resources Recommend Favorite